The Search for a Universal Treatment for Defined and Mixed Pathology Neurodegenerative Diseases
Open Access
- 14 December 2024
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (24) , 13424
Abstract
The predominant neurodegenerative diseases, Alzheimer’s disease, Parkinson’s disease, dementia with Lewy Bodies, Huntington’s disease, amyotrophic lateral sclerosis, and frontotemporal dementia, are rarely pure diseases but, instead, show a diversity of mixed pathologies. At some level, all of them share a combination of one or more different toxic biomarker proteins: amyloid beta (Aβ), phosphorylated Tau (pTau), alpha-synuclein (αSyn), mutant huntingtin (mHtt), fused in sarcoma, superoxide dismutase 1, and TAR DNA-binding protein 43. These toxic proteins share some common attributes, making them potentially universal and simultaneous targets for therapeutic intervention. First, they all form toxic aggregates prior to taking on their final forms as contributors to plaques, neurofibrillary tangles, Lewy bodies, and other protein deposits. Second, the primary enzyme that directs their aggregation is transglutaminase 2 (TGM2), a brain-localized enzyme involved in neurodegeneration. Third, TGM2 binds to calmodulin, a regulatory event that can increase the activity of this enzyme threefold. Fourth, the most common mixed pathology toxic biomarkers (Aβ, pTau, αSyn, nHtt) also bind calmodulin, which can affect their ability to aggregate. This review examines the potential therapeutic routes opened up by this knowledge. The end goal reveals multiple opportunities that are immediately available for universal therapeutic treatment of the most devastating neurodegenerative diseases facing humankind.Keywords
This publication has 178 references indexed in Scilit:
- Cytosolic calcium: Judge, jury and executioner of neurodegeneration in Alzheimer's disease and beyondAlzheimer's & Dementia, 2023
- Aggregation-prone TDP-43 sequesters and drives pathological transitions of free nuclear TDP-43Cellular and Molecular Life Sciences, 2023
- Prevalence and Clinical Phenotype of Quadruple Misfolded Proteins in Older AdultsJAMA Neurology, 2020
- Clinical Features of Alzheimer Disease With and Without Lewy BodiesJAMA Neurology, 2015
- Neuronal calcium signaling: function and dysfunctionCellular and Molecular Life Sciences, 2014
- Protein aggregation in amyotrophic lateral sclerosisActa Neuropathologica, 2013
- Enhanced accumulation of phosphorylated α‐synuclein in double transgenic mice expressing mutant β‐amyloid precursor protein and presenilin‐1Journal of Neuroscience Research, 2007
- ALS-Linked Cu/Zn–SOD Mutation Increases Vulnerability of Motor Neurons to Excitotoxicity by a Mechanism Involving Increased Oxidative Stress and Perturbed Calcium HomeostasisExperimental Neurology, 1999
- The role of calcium‐binding proteins in selective motoneuron vulnerability in amyotrophic lateral sclerosisAnnals of Neurology, 1994
- Calmodulin binds to a tubulin binding site of the microtubule-associated protein tauMolecular and Cellular Biochemistry, 1990